Inhibition of tumor growth and polyamine uptake by tetracyclic amidines bearing a putrescine moiety.
Tetracyclic amidines (tetrahydroquino[4.3-b][l]benzazepine: compound 11 and tetrahydrobenzo[k]naphthyridine: compound 12) bearing a putrescine moiety possess significant DNA-binding affinity. We report here that these compounds and their a and b isomers inhibit tumor cell growth and putrescine uptake in 3LL carcinoma cells in vitro. Moreover, compound 11 reduced by 50% the accumulation of putrescine in intestinal brush border membrane vesicles. In CHO-MG, a cell line deficient for the specific polyamine uptake system, the cytotoxicity of these compounds was significantly reduced compared to the CHO wild cell line. The IC50 for CHO-MG was significantly higher than for CHO, demonstrating that the polyamine transport system increased the efficacy of these compounds. The efficacy of compounds 11 and 12 might therefore be related to their ability to interact with DNA as well as their structural analogy with polyamines. Moreover, we clearly show that DFMO enhances the efficacy of these tetracyclic amidines in vivo. Potential mechanisms include: a) lower intracellular polyamine levels reduces polyamine DNA-stabilizing functions, increasing accessibility for DNA-binding drugs; b) DFMO enhances the polyamine uptake system in tumor cells, increasing the entry of tetracyclic amidines bearing a putrescine moiety as well as their accessibility to final DNA-binding sites. The fact that natural polyamine uptake is reduced by the same compounds constitutes an additive mechanism for antitumoral efficiency.
Mens
T
T
UPRES-A CNRS 6027, Faculté de Médecine de Rennes, France.
Tomasi
S
S
Eifler-Lima
V L
VL
Uriac
P
P
Huet
J
J
Catros-Quemener
V
V
D000578:Amidines / Q000633:toxicity*; D000818:Animals; D001552:Benzazepines / Q000633:toxicity*; D001692:Biological Transport / Q000187:drug effects; D016466:CHO Cells; D002455:Cell Division / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D006224:Cricetinae; D000518:Eflornithine / Q000494:pharmacology; D007413:Intestinal Mucosa / Q000187:drug effects / Q000378:metabolism; D008175:Lung Neoplasms / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology*; D051379:Mice; D008871:Microvilli / Q000187:drug effects / Q000378:metabolism; D011700:Putrescine / Q000031:analogs & derivatives* / Q000378:metabolism*; D011804:Quinolines / Q000633:toxicity*; D051381:Rats
D000578:Amidines; D001552:Benzazepines; D011804:Quinolines; C111035:tetrahydroquino(4,3-b)benzazepine; D011700:Putrescine; D000518:Eflornithine